Deerfield Management Company »

Hims & Hers Heal shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Hims & Hers Heal (HIMS) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Hims & Hers Heal

Tip: Access up to 7 years of quarterly data

All positions including Hims & Hers Heal held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hims & Hers Heal by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $137k 15k 8.90

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Hims & Hers Heal

Vanguard Group
Redpoint Management
Marshall Wace
Bank of America Corporation
Citadel Advisors
Dimensional Fund Advisors
Millennium Management
Franklin Resources
Susquehanna International
Charles Schwab Investment Management
Cubist Systematic Strategies
Goldman Sachs Group
Alliancebernstein
Jupiter Asset Management
Federated Investors

View all funds holding Hims & Hers Heal